SCHEMBL7501949

SCHEMBL7501949

CCC1CCC(=O)N2CCc3c([nH]c4ccc(OC)cc34)C12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SIGMAR1 Q99720 2/20 0.55
▸ SLC6A4 P31645 2/20 0.55
▸ CHRNB2 P17787 1/20 0.55
▸ CHRNB4 P30926 1/20 0.55
▸ CHRNA3 P32297 1/20 0.55
▸ CHRNA4 P43681 1/20 0.55
▸ KCNH2 Q12809 1/20 0.55
▸ TMEM97 Q5BJF2 1/20 0.55
▸ MAPKAPK2 P49137 6/20 0.54
▸ TRPA1 O75762 3/20 0.49
▸ TRPV1 Q8NER1 2/20 0.49
▸ SIRT1 Q96EB6 1/20 0.48
▸ MAPT P10636 3/20 0.47
▸ ALDH1A1 P00352 1/20 0.47
▸ HTR2B P41595 1/20 0.47
▸ TP53 P04637 3/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ MAPKAPK5 Q8IW41 1/20 0.46
▸ KMT2A Q03164 1/20 0.45
▸ KDR P35968 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7504696 0.89 MAPKAPK2 (0.49) SIGMAR1SLC6A4CHRNB2CHRNB4CHRNA3
SCHEMBL7505086 0.88 SIGMAR1 (0.57) SIGMAR1SLC6A4CHRNB2CHRNB4CHRNA3
SCHEMBL7507230 0.83 TP53 (0.52) SIGMAR1SLC6A4CHRNB2CHRNB4CHRNA3
SCHEMBL7503170 0.82 MAPKAPK2 (0.54) SIGMAR1SLC6A4CHRNB2CHRNB4CHRNA3
SCHEMBL8041821 0.82 MAPKAPK2 (0.50) SIGMAR1SLC6A4CHRNB2CHRNB4CHRNA3
SCHEMBL7506585 0.82 MAPKAPK2 (0.53) SIGMAR1SLC6A4CHRNB2CHRNB4CHRNA3
SCHEMBL7504077 0.81 MAPKAPK2 (0.49) SIGMAR1SLC6A4CHRNB2CHRNB4CHRNA3
SCHEMBL6237350 0.81 MAPKAPK2 (0.55) SIGMAR1SLC6A4CHRNB2CHRNB4CHRNA3
SCHEMBL7510021 0.80 TP53 (0.56) SIGMAR1SLC6A4CHRNB2CHRNB4CHRNA3
SCHEMBL7506122 0.80 MAPKAPK2 (0.48) SIGMAR1SLC6A4CHRNB2CHRNB4CHRNA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1064284-B1 HYPNOTIC BETA-CARBOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICINAL PRODUCTS MACEF (FR) 2002-03-27 — — EP claimed
US-6048868-A CIRCADIAN RHYTHM DISORDERS; SLEEP DISORDERS; ANTIDEPRESSANTS CEMAF (FR) 2000-04-11 — — US claimed
EP-1091959-B1 NOVEL PYRROLO-(3,4-B)QUINOLINE DERIVATIVES, METHOD FOR THE PRODUCTION AND USE THEREOF AS A MEDICAMENT MACEF (FR) 2002-10-23 — — EP disclosed
EP-1064284-B1 HYPNOTIC BETA-CARBOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICINAL PRODUCTS MACEF (FR) 2002-03-27 — — EP disclosed
WO-2000069875-A9 C-2 MODIFIED ERYTHROMYCIN DERIVATIVES ABBOTT LAB (US) 2002-02-21 — — WO disclosed
US-6335346-B1 HYPNOTIC AGENTS, SEDATIVES MACEF (FR) 2002-01-01 — — US disclosed
US-6048868-A CIRCADIAN RHYTHM DISORDERS; SLEEP DISORDERS; ANTIDEPRESSANTS CEMAF (FR) 2000-04-11 — — US disclosed
EP-0929563-A1 6-O-SUBSTITUTED KETOLIDES HAVING ANTIBACTERIAL ACTIVITY Abbott Laboratories (US) 1999-07-21 — — EP disclosed
WO-1998009978-A1 6-O-SUBSTITUTED KETOLIDES HAVING ANTIBACTERIAL ACTIVITY ABBOTT LABORATORIES (US) 1998-03-12 — — WO disclosed
Send feedback